Gefitinib / preliminary population pharmacokinetic analysis from a nested case-control study

スポンサーリンク

概要

• 論文の詳細を見る
• 2005-01-01

著者

• Tanigawara Yusuke

  Department Of Clinical Pharmacokinetics And Pharmacodynamics School Of Medicine Keio University

• Kawata Toshio

  Pharmacokinetic Group Astrazeneca K. K.

• Sato Reiko

  Department Of Pharmacy Keio University School Of Medicine

関連論文

• 高血圧症患者におけるオルメサルタン及びアゼルニジピンの比較薬力学 : 母集団薬物動態 / 薬力学解析
• S22-3 Pharmaco-proteomics and metabolomics for personalized medicine(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
• Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
• MEAN RESIDENCE TIME IN ORGANS IN TOXICOKINETIC STUDIES
• 健康成人における塩酸ランジオロールの母集団薬物動態モデルの構築
• Reversal Effects of Ca2+ Antagonists on Multidrug Resistance via Down-regulation of MDR1 mRNA
• Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
• MDR1-Mediated Interaction of Digoxin with Antiarrhythmic or Antianginal Drugs
• Factors Influencing the Prediction of Steady State Concentrations of Digoxin
• Interaction of Docetaxel ("Taxotere") with Human P-Glycoprotein
• Cellular Pharmacokinetic Aspects of Reversal Effect of Itraconazole on P-Glycoprotein-Mediated Resistance of Anticancer Drugs
• Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P-Glycoprotein
• Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
• N-Acetyltransferase2 Genotype Correlated with Isoniazid Acetylation in Japanese Tuberculous Patients
• Effects of Secretable SOD Delivered by Genetically Modified Cells on Xanthine/Xanthine Oxidase and Paraquat-Induced Cytotoxicity in Vitro
• Effects of Cu, Zn-Superoxide Dismutase Delivered by Genetically Modified Skin Fibroblasts on Cold-Induced Skin Edema in Rats
• Protective Effect of Transfection with Secretable Superoxide Dismutase (SOD) (a Signal Sequence-SOD Fusion Protein Coding cDNA) Expression Vector on Superoxide Anion-Induced Cytotoxicity in Vitro)
• Effect of Transfection with a Superoxide Dismutase Expression Plasmid on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Cultured Rat Lung Cells
• Pharmaceutical Studies for Gene Therapy : Expression of Human Cu, Zn-Superoxide Dismutase Gene Transfected by Lipofection in Rat Skin Fibroblasts
• Effect of Transfection with Superoxide Dismutase Expression Plasmid on Superoxide Anion Induced Cytotoxicity in Cultured Rat Lung Cells
• Pharmacodynamic analysis of vancomycin effect alone and with serum proteins : using a novel in vitro model
• N-Acetyltransferase 2 Genotype-Related Sulfapyridine Acetylation and Its Adverse Events
• Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers
• ミカファンギンの小児適応のためのポピュレーションPK解析
• Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections(Biopharmacy)
• A novel proteomic approach to determine possible biomarkers for acute rejection after small bowel transplantation
• Discovery of new biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat liver transplantation : a comprehensive gene expression analysis
• A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam
• Influence of N-Terminal Peptide and Oligosaccharide on the Clearance of t-PA
• The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P-Glycoprotein
• Influence of Sugar Chain on Fibrin Affinity of Recombinat t-PA
• New biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat cardiac transplantation by cDNA microarray analysis
• Relationship between Pharmacokinetic Parameters and Occurrence of Adverse Events in Clinical Trials Performed in Europe and United States for an Angiotensin II Receptor Antagonist, Telmisartan
• Pharmacokinetic Comparison of an Angiotensin II Receptor Antagonist, Telmisartan, in Japanese and Western Hypertensive Patients Using Population Pharmacokinetic Method
• Phorbol Myristate Acetate Stimulates Degradation of a Structural Analogue of Platelet-Activating Factor to a Neutral Lipid in Human Leukemic K562 Cells : Relevance to the Release of Lipids(Biochemistry/Molecular Biology)
• Prediction of the efficacy and safety of pioglitazone in patients with type 2 diabetes mellitus
• Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs
• Population Pharmacokinetics of an Angiotensin II Receptor Antagonist, Telmisartan, in Healthy Volunteers and Hypertensive Patients
• Population pharmacokinetics (PK) and pharmacodynamics (PD) of arbekacin in patients infected with methicillin-resistant Staphylococcus aureus (MRSA)
• Gefitinib / preliminary population pharmacokinetic analysis from a nested case-control study
• Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis
• Lamotrigine Treatment for Affective Instability in Adolescents With Borderline Personality Disorder
• Clinical dose findings of sitafloxacin treatment : pharmacokinetic-pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections
• Practice guidelines for therapeutic drug monitoring of voriconazole : a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

もっと見る 閉じる

スポンサーリンク